IMPACt of an Enhanced Screening Program on the Detection of Non-AIDS NEOplasms in HIV Patients
Conditions: HIV/AIDS; Cancer Interventions: Diagnostic Test: Digital rectal exam and / or anal cytology (day 1 and after 36 months); Diagnostic Test: Semestral digital rectal exam and / or anal cytology if abnormal → ANOSCOPY with biopsy; Diagnostic Test: Cervical cytology and cervical sample for HPV detection (day 1 and after 36 months); Diagnostic Test: Semestral cervical cytology and cervical sample for HPV detection; Diagnostic Test: Appointment for mammography (day 1 and after 36 months); Diagnostic Test: Annual appointment for mammography; Diagnostic Test: Semestral appointment for liver ultrasound; Diag nostic Test: Semestral blood collection for alpha-fetoprotein and others hepatic biomarkers determination; Diagnostic Test: Fecal occult blood test (day 1 and after 36 months); Diagnostic Test: Annual fecal occult blood test; Diagnostic Test: Digital rectal exam and PSA determination (day 1 and after 36 months); Diagnostic Test: Annual digital rectal exam and PSA determination; Diagnostic Test: Annual appointment for low dose computed tomography for lung screening; Diagnostic Test: Annual general inspection for skin lesions suggestive of malignancy Sponsors: Felix Gutierrez; Instituto de Salud Carlos III (Funding reference PI18/01861); Hospital General Universitario Reina Sofía de Murcia; Hospital Universitario Reina Sofia de Cordoba; Hospital General Universitario de Alicante; Hospital...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anoscopy | Cancer | Cancer & Oncology | Cervical Cancer | CT Scan | Cytology | Funding | HIV AIDS | Hospitals | Liver | Mammography | Research | Skin | Skin Biopsy | Ultrasound | Urology & Nephrology